Aemetis, Inc. (NASDAQ:AMTX) Short Interest Update

Aemetis, Inc. (NASDAQ:AMTX) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,320,000 shares, a growth of 14.7% from the March 15th total of 4,640,000 shares. Based on an average daily trading volume, of 1,220,000 shares, the short-interest ratio is presently 4.4 days.

Hedge Funds Weigh In On Aemetis

A number of hedge funds have recently modified their holdings of AMTX. Point72 Asset Management L.P. bought a new position in shares of Aemetis in the second quarter worth approximately $25,000. Barclays PLC boosted its position in shares of Aemetis by 542.0% in the fourth quarter. Barclays PLC now owns 8,031 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 6,780 shares during the period. Tower Research Capital LLC TRC boosted its position in shares of Aemetis by 173.7% in the third quarter. Tower Research Capital LLC TRC now owns 5,586 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 3,545 shares during the period. Deutsche Bank AG boosted its position in shares of Aemetis by 66.9% in the first quarter. Deutsche Bank AG now owns 18,454 shares of the specialty chemicals company’s stock worth $43,000 after purchasing an additional 7,395 shares during the period. Finally, BNP Paribas Arbitrage SA boosted its position in shares of Aemetis by 105.6% in the second quarter. BNP Paribas Arbitrage SA now owns 9,517 shares of the specialty chemicals company’s stock worth $47,000 after purchasing an additional 4,887 shares during the period. 27.02% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

AMTX has been the subject of several recent analyst reports. Stifel Nicolaus decreased their target price on shares of Aemetis from $8.00 to $6.50 and set a “buy” rating for the company in a report on Wednesday, February 21st. Truist Financial decreased their target price on shares of Aemetis from $5.00 to $3.50 and set a “hold” rating for the company in a report on Tuesday, January 23rd.

Aemetis Stock Performance

Shares of AMTX traded down $0.21 during mid-day trading on Monday, hitting $4.08. 608,112 shares of the company traded hands, compared to its average volume of 1,168,221. The stock has a 50-day moving average price of $4.08 and a two-hundred day moving average price of $4.34. Aemetis has a 1 year low of $1.16 and a 1 year high of $8.99. The stock has a market cap of $173.84 million, a price-to-earnings ratio of -3.09 and a beta of 1.01.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Thursday, March 7th. The specialty chemicals company reported ($0.34) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.35) by $0.01. The business had revenue of $70.76 million for the quarter, compared to the consensus estimate of $80.08 million. During the same quarter last year, the firm posted ($0.63) earnings per share. On average, analysts forecast that Aemetis will post -1.44 EPS for the current year.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.